Misha Miroslav Backonja

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi Use of anticonvulsants for treatment of neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Hospital and Clinics, Room H6 574, 600 Highland Avenue, Madison, WI 53792 5132, USA
    Neurology 59:S14-7. 2002
  2. ncbi Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial
    M Backonja
    Department of Neurology, University of Wisconsin, Madison 53792, USA
    JAMA 280:1831-6. 1998
  3. ncbi Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities
    Miroslav Misha Backonja
    Department of Neurology, University of Wisconsin Madison, 600 Highland Avenue, Madison, WI 53792, USA
    Clin J Pain 25:641-7. 2009
  4. ncbi NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study
    Miroslav Backonja
    University of Wisconsin Madison, Madison, WI 53792, USA
    Lancet Neurol 7:1106-12. 2008
  5. ncbi Rational multidrug therapy in the treatment of neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Madison, 53792, USA
    Curr Pain Headache Rep 10:34-8. 2006
  6. ncbi Neuropathic pain symptoms relative to overall pain rating
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Madison, Madison, Wisconsin 53792, USA
    J Pain 5:491-7. 2004
  7. ncbi Neuromodulating drugs for the symptomatic treatment of neuropathic pain
    Miroslav Backonja
    University of Wisconsin Hospital, Department of Neurology H6 570, 600 Highland Avenue, Madison, WI 53792, USA
    Curr Pain Headache Rep 8:212-6. 2004
  8. ncbi Neuropathic pain questionnaire--short form
    Misha-Miroslav Backonja
    Department of Neurology, University of Wisconsin, Madison, Wisconsin 53792, USA
    Clin J Pain 19:315-6. 2003
  9. ncbi Defining neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Medical School, University of Wisconsin, Madison 53792, USA
    Anesth Analg 97:785-90. 2003
  10. ncbi Anticonvulsants (antineuropathics) for neuropathic pain syndromes
    M M Backonja
    Department of Neurology, University of Wisconsin, Madison, USA
    Clin J Pain 16:S67-72. 2000

Detail Information

Publications30

  1. ncbi Use of anticonvulsants for treatment of neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Hospital and Clinics, Room H6 574, 600 Highland Avenue, Madison, WI 53792 5132, USA
    Neurology 59:S14-7. 2002
    ..Evidence supporting the efficacy of anticonvulsants in treatment of such pain is evolving. Additional clinical trials should provide information that will better define their role in neuropathic pain...
  2. ncbi Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial
    M Backonja
    Department of Neurology, University of Wisconsin, Madison 53792, USA
    JAMA 280:1831-6. 1998
    ..Pain is the most disturbing symptom of diabetic peripheral neuropathy. As many as 45% of patients with diabetes mellitus develop peripheral neuropathies...
  3. ncbi Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities
    Miroslav Misha Backonja
    Department of Neurology, University of Wisconsin Madison, 600 Highland Avenue, Madison, WI 53792, USA
    Clin J Pain 25:641-7. 2009
    ..Together with the companion manuscript, this review provides definitions that should help further the use of QST as a diagnostic tool as well...
  4. ncbi NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study
    Miroslav Backonja
    University of Wisconsin Madison, Madison, WI 53792, USA
    Lancet Neurol 7:1106-12. 2008
    ..We report the results of a randomised, double blind, 12-week study of the efficacy and safety of one application of NGX-4010 in patients with PHN...
  5. ncbi Rational multidrug therapy in the treatment of neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Madison, 53792, USA
    Curr Pain Headache Rep 10:34-8. 2006
    ..MDT for neuropathic pain is based on a comprehensive clinical neuropathic pain assessment and ongoing monitoring of the drug therapy's efficacy and adverse effects, administering one drug at the time...
  6. ncbi Neuropathic pain symptoms relative to overall pain rating
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Madison, Madison, Wisconsin 53792, USA
    J Pain 5:491-7. 2004
    ..Further research of this type can contribute to advances in mechanism-based diagnosis and treatment...
  7. ncbi Neuromodulating drugs for the symptomatic treatment of neuropathic pain
    Miroslav Backonja
    University of Wisconsin Hospital, Department of Neurology H6 570, 600 Highland Avenue, Madison, WI 53792, USA
    Curr Pain Headache Rep 8:212-6. 2004
    ..A number of available anticonvulsants are undergoing clinical trials and many drugs with neuromodulatory properties are being considered for further development...
  8. ncbi Neuropathic pain questionnaire--short form
    Misha-Miroslav Backonja
    Department of Neurology, University of Wisconsin, Madison, Wisconsin 53792, USA
    Clin J Pain 19:315-6. 2003
  9. ncbi Defining neuropathic pain
    Misha Miroslav Backonja
    Department of Neurology, University of Wisconsin Medical School, University of Wisconsin, Madison 53792, USA
    Anesth Analg 97:785-90. 2003
    ....
  10. ncbi Anticonvulsants (antineuropathics) for neuropathic pain syndromes
    M M Backonja
    Department of Neurology, University of Wisconsin, Madison, USA
    Clin J Pain 16:S67-72. 2000
    ..More advances in our understanding of the mechanisms underlying neuropathic pain syndromes should further our opportunities to establish the role of anticonvulsants in the treatment of neuropathic pain...
  11. ncbi Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials
    Miroslav Backonja
    Department of Neurology, Anesthesiology, and Rehabilitation Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin 53792, USA
    Clin Ther 25:81-104. 2003
    ..Tricyclic antidepressants are considered first-line agents for neuropathic pain, but their use is limited by unwanted side effects and a risk of cardiovascular mortality...
  12. ncbi Anticonvulsants for the treatment of neuropathic pain syndromes
    Miroslav Backonja
    University of Wisconsin Hospital, Department of Neurology H6 570, 600 Highland Avenue, Madison, WI 53792, USA
    Curr Pain Headache Rep 7:39-42. 2003
    ..This article is an evidence-based summary of randomized clinical trials published in peer-reviewed journals regarding the efficacy of anticonvulsants for the treatment of neuropathic pain...
  13. ncbi Individual differences in the effects of perceived controllability on pain perception: critical role of the prefrontal cortex
    Tim V Salomons
    University of Wisconsin Madison, WI, USA
    J Cogn Neurosci 19:993-1003. 2007
    ....
  14. ncbi NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension
    Misha Miroslav Backonja
    University of Wisconsin Madison, Madison, Wisconsin, USA
    Pain Med 11:600-8. 2010
    ..To assess the efficacy, tolerability, and safety of NGX-4010, a high-concentration capsaicin dermal patch (capsaicin 640 microg/cm(2), 8%) in patients with postherpetic neuralgia (PHN)...
  15. ncbi Development of a neuropathic pain questionnaire
    Steven J Krause
    Department of Orthopedics and Rehabilitation Medicine, University of Wisconsin, Madison, Wisconsin, USA
    Clin J Pain 19:306-14. 2003
    ..Consequently, it can be used for monitoring of neuropathic pain treatments and as an outcome measure...
  16. ncbi Classification of patients with pain based on neuropathic pain symptoms: comparison of an artificial neural network against an established scoring system
    Michael Behrman
    Department of Mathematics, University of Wisconsin Madison, Madison, WI, USA
    Eur J Pain 11:370-6. 2007
    ..Data analysis with ANNs provides a framework that extends what current approaches offer, especially for dynamic data, such as the rating of pain descriptors over time...
  17. ncbi Mechanistic stratification of antineuralgic agents
    Ahmad Beydoun
    Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
    J Pain Symptom Manage 25:S18-30. 2003
    ....
  18. ncbi Pain ratings at the thresholds are necessary for interpretation of quantitative sensory testing
    Kiesa Getz Kelly
    Department of Neurology, University of Wisconsin, 600 Highland Avenue, Madison, Wisconsin 53792, USA
    Muscle Nerve 32:179-84. 2005
    ..Suggestions are provided for combining threshold information for innocuous and noxious stimuli and related pain ratings for the evaluation of sensory nervous system function and, specifically, neuropathic pain...
  19. ncbi Pharmacologic management part 1: better-studied neuropathic pain diseases
    Misha-Miroslav Backonja
    University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA
    Pain Med 5:S28-47. 2004
    ..Looking to the future, emerging therapies, such as pregabalin and newer N-methyl-D-aspartate-receptor blockers, may provide physicians and patients with new treatment options for more effective relief of pain...
  20. ncbi Pharmacologic management part 2: lesser-studied neuropathic pain diseases
    Misha-Miroslav Backonja
    University of Wisconsin Hospital and Clinics, Madison, Wisconsin, USA
    Pain Med 5:S48-59. 2004
    ....
  21. ncbi Voluntary facial displays of pain increase suffering in response to nociceptive stimulation
    Tim V Salomons
    Waisman Laboratory for Brain Imaging and Behavior, Waisman Center, Madison, Wisconsin 53705, USA
    J Pain 9:443-8. 2008
    ..This suggests that exaggerated facial displays of pain, although often socially reinforced, may also have unintended aversive consequences...
  22. ncbi A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain
    Ivo W Tremont-Lukats
    Department of Neurology, University of Wisconsin-Madison, Madison, WI 53792, USA
    Clin J Pain 22:266-71. 2006
    ..Additional research is needed using higher infusion rates with larger sample sizes to confirm these results and to explore the role of MEGX in the relief of neuropathic pain...
  23. ncbi Perceived controllability modulates the neural response to pain
    Tim V Salomons
    W. M. Keck Laboratory for Functional Brain Imaging and Behavior, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA
    J Neurosci 24:7199-203. 2004
    ....
  24. ncbi Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies
    Daniel K Kajdasz
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Clin Ther 29:2536-46. 2007
    ....
  25. ncbi Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study
    Russell K Portenoy
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    Clin J Pain 23:287-99. 2007
    ..To evaluate the outcomes associated with the use of controlled-release (CR) oxycodone for up to 3 years in the treatment of noncancer pain...
  26. ncbi Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain
    Charles E Argoff
    New York University School of Medicine and Cohn Pain Management Center, North Shore University Hospital, Manhasset, NY, USA
    Mayo Clin Proc 81:S12-25. 2006
    ..Ultimately, treatment choice must also Include consideration of adverse effects, individual patient factors such as comorbidities, and often cost...
  27. ncbi Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    Carmel Armon
    Division of Neurology, Baystate Medical Center, Springfield, MA, USA
    Neurology 68:723-9. 2007
    ....
  28. ncbi New perspectives on the management of diabetic peripheral neuropathic pain
    Troels S Jensen
    Department of Endocrinology, Diabetology and Nutrition, Hôpital Jean Verdier APHP Paris Nord University, Bondy, France
    Diab Vasc Dis Res 3:108-19. 2006
    ..Irrespective of which treatment is offered, only about one third of patients are likely to achieve more than 50% pain relief. Further research to improve the diagnosis and management of DPNP is needed...
  29. ncbi Quantitative sensory testing for spinal cord stimulation in patients with chronic neuropathic pain
    Elon Eisenberg
    Pain Relief Unit, Rambam Medical Center, Haifa Pain Research Group, Technion Israel Institute of Technology, Haifa, Israel
    Pain Pract 6:161-5. 2006
    ..Participants: Thirteen patients with radicular leg pain due to failed back surgery syndrome (FBSS) or leg pain due to complex regional pain syndrome (CRPS) who were candidates for SCS...
  30. ncbi Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    William M Landau
    Neurology 69:614; author reply 614-5. 2007